Approval of inhaled insulin in Europe and United States
نویسندگان
چکیده
منابع مشابه
Public Diplomacy and its Institutions in United States of America
Although, once, in the far past, sending gifts and missionaries was called a type of public diplomacy, today it is manifested as academic disciplines, policy making institutions, and multi-purpose organizations. The most important institutions of these kinds, now, exist in the US, whose purpose is to promote the politics of this country as Public Diplomacy and to follow local and international ...
متن کاملHealth System Reform in the United States
In 2010, the United States adopted its first-ever comprehensive set of health system reforms in the Affordable Care Act (ACA). Implementation of the law, though politically contentious and controversial, has now reached a stage where reversal of most elements of the law is no longer feasible. The controversial portions of the law that expand affordable health insurance coverage to most U.S. cit...
متن کاملRace, Education Attainment, and Happiness in the United States
Background and aims: As suggests by the Minorities’ Diminished Returns (MDR) theory, educationattainment and other socioeconomic status (SES) indicators have a smaller impact on the health andwell-being of non-White than White Americans. To test whether MDR also applies to happiness, in thepresent study, Blacks and Whites were compared in terms of the effect of education attai...
متن کاملFeminism and Abortion in the United States’ Party Politics
Abstract The feminist movement in the United States like other countries has tried to establish equality for women. From the first attempts to gain constitutional right for vote, up to the current radical demands, feminists have struggled to make changes in the U.S. party politics and obtain their rights within the parties. One of the important issues in which women played a key role in party ...
متن کاملLorcaserin approval in the United States: paving the way?
For over a decade, the world of obesity pharmaceuticals has been stagnant, with most medications that have been studied for use in the management of obesity being rejected or withdrawn due to an unacceptable side effect profile. Since the withdrawal of sibutramine in 2010 due to concerns regarding an increased risk of cardiovascular events, the only available medical therapy is orlistat, which ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2006
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.332.7543.730-b